Vesta Therapeutics

Vesta Therapeutics was a regenerative medicine company focused on developing cell-based therapies for chronic and acute liver diseases. The company's core technology centered on the isolation, expansion, and clinical application of human hepatic stem cells and progenitor cells, primarily based on the research of founder Dr. Lola Reid. Their therapeutic approach aimed to restore liver function and provide a viable alternative to whole-organ transplantation for patients with conditions such as liver failure and cirrhosis. Although the company made significant strides in characterizing liver progenitor populations, it is no longer active in the commercial biotechnology sector.